Nanocytological Field Carcinogenesis Detection to Mitigate Overdiagnosis of Prostate Cancer: A Proof of Concept Study
暂无分享,去创建一个
Vadim Backman | Hemant K. Roy | Hariharan Subramanian | Charles B. Brendler | John Chandler | V. Backman | B. Helfand | C. Brendler | H. Subramanian | Di Zhang | H. Roy | J. Chandler | Leah Bowen | Jacqueline Petkewicz | Chihsiung Wang | K. Kaul | Di Zhang | Charles Maneval | Leah Bowen | Karen L. Kaul | Brian T. Helfand | Chi-Hsiung Wang | Margo Quinn | Jacqueline Petkewicz | Michael Paterakos | Margo Quinn | M. Paterakos | C. Maneval | Chi-hsiung Wang
[1] D. Moreira,et al. Smoking and prostate cancer survival and recurrence. , 2011, Asian journal of andrology.
[2] Vadim Backman,et al. Optical detection of buccal epithelial nanoarchitectural alterations in patients harboring lung cancer: implications for screening. , 2010, Cancer research.
[3] P. Corso,et al. National Institutes of Health State-of-the-Science Conference: Role of Active Surveillance in the Management of Men With Localized Prostate Cancer , 2012, Annals of Internal Medicine.
[4] A. Jemal,et al. Cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.
[5] D. Moore,et al. Alteration of Gene Expression in Normal-Appearing Colon Mucosa of APCmin Mice and Human Cancer Patients , 2004, Cancer Research.
[6] P. Carroll,et al. The relationship between anxiety and time to treatment for patients with prostate cancer on surveillance. , 2007, The Journal of urology.
[7] Vadim Backman,et al. Nanocytology of rectal colonocytes to assess risk of colon cancer based on field cancerization. , 2012, Cancer research.
[8] J. Stanford,et al. Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle‐aged men , 2007, Cancer.
[9] H Ballentine Carter,et al. American Urological Association (AUA) Guideline on prostate cancer detection: process and rationale , 2013, BJU international.
[10] T. H. van der Kwast,et al. Prevalence of prostate cancer on autopsy: cross-sectional study on unscreened Caucasian and Asian men. , 2013, Journal of the National Cancer Institute.
[11] J. Epstein,et al. Pathological examination of radical prostatectomy specimens in men with very low risk disease at biopsy reveals distinct zonal distribution of cancer in black American men. , 2014, The Journal of urology.
[12] Vadim Backman,et al. Nanoscale markers of esophageal field carcinogenesis: potential implications for esophageal cancer screening , 2013, Endoscopy.
[13] Identification of FISH biomarkers to detect chromosome abnormalities associated with prostate adenocarcinoma in tumour and field effect environment , 2014, BMC Cancer.
[14] M. Cooperberg,et al. Racial variation in prostate cancer upgrading and upstaging among men with low-risk clinical characteristics. , 2015, European urology.
[15] J. Rathmell,et al. Results of the two incidence screenings in the National Lung Screening Trial. , 2013, The New England journal of medicine.
[16] J. Griffith,et al. Markers of Field Cancerization: Proposed Clinical Applications in Prostate Biopsies , 2012, Prostate cancer.
[17] Vadim Backman,et al. Nanoscale cellular changes in field carcinogenesis detected by partial wave spectroscopy. , 2009, Cancer research.
[18] P. Corso,et al. National Institutes of Health State-of-the-Science Conference , 2012 .
[19] V. Backman,et al. Advances in Biophotonics Detection of Field Carcinogenesis for Colon Cancer Risk Stratification , 2013, Journal of Cancer.
[20] Allen Taflove,et al. Optical methodology for detecting histologically unapparent nanoscale consequences of genetic alterations in biological cells , 2008, Proceedings of the National Academy of Sciences.
[21] F. Guimont,et al. Mitochondria, prostate cancer, and biopsy sampling error. , 2013, Discovery medicine.
[22] Vadim Backman,et al. Role of cytoskeleton in controlling the disorder strength of cellular nanoscale architecture. , 2010, Biophysical journal.
[23] Brian Reid,et al. Overdiagnosis and overtreatment in cancer: an opportunity for improvement. , 2013, JAMA.
[24] T. Gomes,et al. National Institutes of Health State-of-the-Science Conference: role of active surveillance in the management of men with localized prostate cancer. , 2012 .
[25] D. Chan,et al. Biomarkers in prostate cancer: what's new? , 2014, Current opinion in oncology.
[26] Stacey A. Kenfield,et al. Smoking and prostate cancer survival and recurrence. , 2011, JAMA.
[27] Andrew H. Beck,et al. Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression , 2015, Modern Pathology.
[28] Vadim Backman,et al. Insights into the field carcinogenesis of ovarian cancer based on the nanocytology of endocervical and endometrial epithelial cells , 2013, International journal of cancer.
[29] George Vasmatzis,et al. Shared gene expression alterations in prostate cancer and histologically benign prostate from patients with prostate cancer. , 2012, The American journal of pathology.
[30] P. Carroll,et al. A commentary on PSA velocity and doubling time for clinical decisions in prostate cancer. , 2014, Urology.
[31] J. Patard,et al. Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy. , 2009, European urology.
[32] Theodore L DeWeese,et al. Clinical practice. Localized prostate cancer. , 2007, The New England journal of medicine.
[33] Vadim Backman,et al. Light-scattering technologies for field carcinogenesis detection: a modality for endoscopic prescreening. , 2011, Gastroenterology.
[34] W. Zimmer,et al. New concepts concerning prostate cancer screening , 2014, Experimental biology and medicine.
[35] Kenji Ikeda,et al. Gene expression in fixed tissues and outcome in hepatocellular carcinoma. , 2008, The New England journal of medicine.
[36] R. Montironi,et al. Nuclear changes in the normal-looking columnar epithelium adjacent to and distant from prostatic intraepithelial neoplasia and prostate cancer , 2000, Virchows Archiv.
[37] V. Moyer,et al. Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2012, Annals of Internal Medicine.
[38] Avrum Spira,et al. The Field of Tissue Injury in the Lung and Airway , 2008, Cancer Prevention Research.
[39] Vijayalakshmi Ananthanarayanan,et al. Evidence for field cancerization of the prostate , 2009, The Prostate.
[40] Theodore L. DeWeese,et al. Localized Prostate Cancer , 2007 .
[41] G. Tseng,et al. Genome-wide methylation analysis of prostate tissues reveals global methylation patterns of prostate cancer. , 2013, The American journal of pathology.
[42] G. Dotto. Multifocal epithelial tumors and field cancerization: stroma as a primary determinant. , 2014, The Journal of clinical investigation.
[43] V. Backman,et al. Nanocytology for field carcinogenesis detection: novel paradigm for lung cancer risk stratification. , 2011, Future oncology.
[44] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[45] Andrea Califano,et al. A Molecular Signature Predictive of Indolent Prostate Cancer , 2013, Science Translational Medicine.